Results 121 to 130 of about 29,486 (214)

Moderna (mRNA Vaccine) for COVID-19: A Leap in Vaccine World

Pharmaceutical and Biomedical Research, 2022
In December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) appeared and spread worldwide, triggering a pandemic of respiratory illness. So, there was an urgent need for vaccines worldwide.
Anita Rani Bhatia, Arpita Saxena, Nitin Tyagi, Peyir Bagra, Paarth Bhatia   +4 more
doaj  

Impact of BNT162b2 and mRNA-1273 Vaccination on Vascular Function in Healthy Adults: A Pilot Study [PDF]

, 2023
Corinna Serviente, Alexs A. Matias, Mia Calderone, Muhammet Enes Erol, Stuart R. Chipkin, Gwenaël Layec   +5 more
openalex   +1 more source

SARS-CoV-2 vaccination at a High-Complexity Reference Hospital: Implementation and results of an active pharmacovigilance program [PDF]

Programa de Doctorat en Medicina i Recerca Translacional / Tesi realitzada a l'Hospital Clínic[eng] INTRODUCTION: The severe acute respiratory syndrome coronavirus-2 virus (SARS-CoV-2) is the causative agent of the COVID-19 pandemic, which has ...
Sáez Peñataro, Joaquín
core  

Comparison of antibody immune responses between BNT162b2 and mRNA-1273 SARS-CoV-2 vaccines in naïve and previously infected individuals [PDF]

, 2021
Duaa W. Al‐Sadeq, Farah M. Shurrab, Ahmed Ismail, Fathima Humaira Amanullah, Swapna Thomas, Nader Al‐Dewik, Hadi M. Yassine, Hanan F. Abdul Rahim, Laith J. Abu‐Raddad, Gheyath K. Nasrallah   +9 more
openalex   +1 more source

mRNA-1273 cinical development program [PDF]

COVID-02-Miller-508 ...

core  

Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial Tumors [PDF]

, 2021
Madison Ballman, Shannon Swift, Cristina Mullenix, Yvonne Mallory, Chen Zhao, Éva Szabó, Meenakshi Shelat, Susan Sansone, Seth M. Steinberg, Meredith J. McAdams, Arun Rajan   +10 more
openalex   +1 more source

Zona ophtalmique après vaccination par Pfizer BNT162b2 et Moderna mRNA-1273 chez deux patients jeunes et immunocompétents

, 2022
M A Amblard, E Costantini, George Hayek, X Ricaud   +3 more
openalex   +2 more sources

Estimating the Public Health and Economic Impact of Annual mRNA COVID-19 Vaccination for Adults Aged 50 and Older in South Korea’s Endemic Era

Vaccines
Background/Objectives: COVID-19 continues to challenge public health due to emerging variants. To mitigate this, the Korea Disease Control and Prevention Agency (KDCA) recommends annual COVID-19 vaccination, but uptake remains suboptimal.
Jaehee Jung, Dain Lee, Hee-Do Yang, Ah-Young Kim, Haeun Lee, Minkyoung Kang, Ekkehard Beck, Keya Joshi, Youngju Kang, Hye-Young Kang   +9 more
doaj   +1 more source

Phase 1/2 randomized, observer-blind clinical trial of a first-generation, mRNA-based vaccine against seasonal influenza and COVID-19 in healthy adults

Human Vaccines & Immunotherapeutics
A multicomponent vaccine against seasonal influenza and COVID-19 could reduce disease burden in adults by providing simultaneous protection in a single-dose regimen.
Amanda K. Rudman Spergel, Carole Henry, Raffael Nachbagauer, Paulina Kaplonek, Eleanor Astley, Andrei Avanesov, Harry Bertera, Lizbeth Carmona, Deniz Cizmeci, Avi Collins, Alan Embry, Ruiting Guo, Xuezhou Mao, Alicia Pucci, Sarah Shao, Jessica Shih-Lu-Lee, Wen-Han Yu, Daniel Brune, Laurence Chu, Muhammad Irfan, Galit Alter, Jintanat Ananworanich, Christine A. Shaw   +22 more
doaj   +1 more source

Guillian-Barrés syndrom efter mRNA-1273-COVID-19-vaccine

, 2021
Søren Kirchhoff Christensen, Martin Ballegaard, Magnus Spangsberg Boesen   +2 more
openalex   +1 more source